angiotensin ii has been researched along with 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Douglas, SA; Edwards, RM; Elliott, JD; Ohlstein, EH | 1 |
| Bennett, T; Gardiner, SM; Kemp, PA; March, JE; Mullins, JJ | 1 |
| Bennett, T; Gardiner, SM; Kemp, PA; March, JE | 3 |
| Fukamizu, A; Goto, K; Kobayashi, T; Maeda, S; Maki, S; Miyauchi, T; Murakami, K; Sakai, S; Sugishita, Y; Sugiyama, F; Takata, Y | 1 |
| D'Amico, M; Di Filippo, C; Filippelli, A; Rossi, F | 1 |
| Hattori, Y; Jesmin, S; Kitabatake, A; Miyauchi, T; Sakuma, I; Togashi, H; Yoshioka, M | 1 |
8 other study(ies) available for angiotensin ii and 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)-
| Article | Year |
|---|---|
In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.
Topics: Angiotensin II; Animals; Biological Availability; Blood Pressure; Calcitonin Gene-Related Peptide; Carotid Arteries; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelins; Heart Rate; Hemodynamics; Indans; Infusions, Intravenous; Male; Rats; Rats, Sprague-Dawley; Vasodilation | 1995 |
Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Biphenyl Compounds; Endothelin Receptor Antagonists; Endothelins; Hemodynamics; Hypertension; Imidazoles; Indans; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Regional Blood Flow; Tetrazoles | 1995 |
Regional haemodynamic effects of antagonists of angiotensin II, endothelin and adrenoceptors in conscious, vasopressin-deficient, genetically hypertensive rats.
Topics: Adrenergic Antagonists; Angiotensin II; Animals; Biphenyl Compounds; Endothelins; Hemodynamics; Hypertension; Imidazoles; Indans; Losartan; Male; Rats; Sodium Chloride; Tetrazoles; Vasopressins | 1996 |
Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Biphenyl Compounds; Captopril; Endothelins; Endotoxemia; Hemodynamics; Imidazoles; Indans; Lipopolysaccharides; Losartan; Male; Rats; Renal Circulation; Tetrazoles; Vasopressins | 1996 |
Endothelin-1 expression in hearts of transgenic hypertensive mice overexpressing angiotensin II.
Topics: Angiotensin II; Animals; Cardiomegaly; Disease Progression; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Humans; Hypertension; Indans; Male; Mice; Mice, Transgenic; Myocardium; Polymerase Chain Reaction; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger | 1998 |
Endothelin receptor antagonists reduce the pressor effects of angiotensin II into the periaqueductal gray area of rats.
Topics: Angiotensin II; Animals; Azepines; Blood Pressure; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Indans; Indoles; Male; Oligopeptides; Periaqueductal Gray; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin | 1999 |
Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.
Topics: Angiotensin I; Angiotensin II; Animals; Endothelin Receptor Antagonists; Enzyme Inhibitors; Hemodynamics; Hypertension; Indans; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Vasoconstrictor Agents | 1999 |
Effects of endothelin receptor antagonist on expression of AT1 and AT2 receptors in the heart of SHR-SP.
Topics: Angiotensin II; Animals; Coronary Vessels; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Hypertension; Indans; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Endothelin A; Receptor, Endothelin B; Signal Transduction; Stroke | 2004 |